The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalculus Vct Regulatory News (CLC)

Share Price Information for Calculus Vct (CLC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 60.00
Bid: 50.00
Ask: 70.00
Change: 0.00 (0.00%)
Spread: 20.00 (40.00%)
Open: 60.00
High: 60.00
Low: 60.00
Prev. Close: 60.00
CLC Live PriceLast checked at -
Calculus VCT is an Investment Trust

To invest primarily in a diverse portfolio of VCT qualifying UK growth companies whether unquoted or traded on AIM.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM and GM Statement

21 Aug 2023 15:25

RNS Number : 9697J
Calculus VCT PLC
21 August 2023
 

21 August 2023

 

CALCULUS VCT PLC

 

RESULTS OF ANNUAL GENERAL MEETING AND GENERAL MEETING

 

Annual General Meeting

 

The Company is pleased to announce that at the Annual General Meeting held today all resolutions were passed on a show of hands, including the following resolutions 12 to 15:

 

Resolution 12 (special resolution): To authorise the Directors to allot shares for cash pursuant to Sections 570 of the Companies Act 2006

 

Resolution 13 (special resolution): To authorise the Directors to make market purchases of the Company's own shares.

 

Resolution 14 (special resolution): To hold general meetings (other than annual general meetings) on 14 clear days' notice.

 

Resolution 15 (special resolution): To authorize the Directors to apply for the share premium and capital redemption reserve accounts to be cancelled.

 

The proxy votes received on each resolution were as follows:

 

For

At the Chairman's Discretion

Against

Withheld

Resolution 1

3,169,679

98,149

0

0

Resolution 2

2,918,277

123,813

225,738

0

Resolution 3

2,831,205

123,813

298,887

13,923

Resolution 4

3,169,679

98,149

0

0

Resolution 5

2,950,549

121,749

55,673

139,857

Resolution 6

2,847,884

96,085

6,423

317,436

Resolution 7

2,840,214

96,085

6,423

325,106

Resolution 8

2,782,841

110,760

52,833

325,106

Resolution 9

2,983,549

160,699

65,193

58,387

Resolution 10

3,138,715

129,113

0

0

Resolution 11

2,722,427

129,113

293,086

123,202

Resolution 12

2,541,960

131,229

311,769

282,870

Resolution 13

2,955,764

129,113

73,985

108,966

Resolution 14

2,991,326

129,113

93,685

53,704

Resolution 15

2,612,009

129,113

243,836

282,870

 

A copy of the full text of Resolutions 12 to 15 is available for inspection in the Report and Accounts to 28 February 2023 which was previously submitted to the National Storage Mechanism https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

 

 

General Meeting

 

The Company is also pleased to announce that at the General Meeting held today the resolution for the approval of the new performance incentive arrangements as set out in the Circular and Notice of General Meeting dated 17 July 2023 was passed on a show of hands.

 

The resolution was also passed with 82.1% of proxy votes received either for the resolution or at the Chairman's discretion:

 

For

At the Chairman's Discretion

Against

Withheld

Resolution 1

2,575,303

50,230

570,777

99,721

 

A copy of the resolution is available for inspection in the Circular, which was previously submitted to National Storage Mechanism https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

The Circular and the voting results are also available on the Company's website at https://calculuscapital.com/investment-opportunities/calculus-vct/investor-information/.

 

 

Calculus Capital Limited

Company Secretary

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMNKDBBQBKDNFB
Date   Source Headline
24th Apr 20244:49 pmRNSTransaction in Own Shares
5th Apr 20242:54 pmRNSIssue of Equity - 5 April 2024
22nd Feb 20244:38 pmRNSDirectorship Change
15th Feb 202411:53 amRNSIssue of Equity - 15 February 2024
1st Feb 20244:38 pmRNSNet Asset Value - 31 December 2023
10th Jan 20245:27 pmRNSTransaction in Own Shares
21st Dec 202310:08 amRNSDirectorate Change
15th Dec 20233:25 pmRNSIssue of Equity - 15 December 2023
20th Nov 20232:11 pmRNSSeptember 2023 NAV Announcement
13th Nov 20234:46 pmRNSHalf-year Report
22nd Sep 20231:03 pmRNSPublication of a Prospectus
21st Sep 20233:51 pmRNSAppointment of Auditor
7th Sep 20234:57 pmRNSTransaction in Own Shares
30th Aug 202311:28 amRNSStatement re Intention to Raise
25th Aug 20231:19 pmRNSIssue of Equity
21st Aug 20233:25 pmRNSAGM and GM Statement
21st Jul 202312:13 pmRNSIssue of Equity and Total Voting Rights
17th Jul 20233:04 pmRNSPublication of Circular and Notice of GM
3rd Jul 20235:43 pmRNSMay 2023 NAV Announcement
30th Jun 20232:15 pmRNSAnnual Financial Report & Change in Year-End date
5th Apr 20234:52 pmRNSIssue of Equity
5th Apr 20232:40 pmRNSIssue of Equity
15th Mar 20232:45 pmRNSIssue of Equity
9th Mar 20235:31 pmRNSTransaction in Own Shares
9th Mar 20237:00 amRNSTransaction in Own Shares
16th Dec 20223:41 pmRNSIssue of Equity
9th Dec 20225:06 pmRNSNet Asset Value(s)
18th Oct 202211:45 amRNSHalf-year Report
21st Sep 20222:34 pmRNSPublication of a Prospectus
31st Aug 20221:11 pmRNSIssue of Equity
29th Jul 202212:05 pmRNSTotal Voting Rights
14th Jul 20222:48 pmRNSRESULTS OF ANNUAL GENERAL MEETING
30th Jun 20222:03 pmRNSIssue of Equity
29th Jun 20222:37 pmRNSDirector Declaration
29th Jun 202211:45 amRNSNet Asset Value(s)
10th Jun 20225:12 pmRNSTransaction in Own Shares
1st Jun 20227:00 amRNSAnnual Financial Report
5th Apr 202212:23 pmRNSIssue of Equity
22nd Mar 20221:40 pmRNSIssue of Equity
1st Feb 20223:59 pmRNSNet Asset Value(s)
17th Dec 20211:08 pmRNSShare allotment and Total Voting Rights
12th Nov 20214:30 pmRNSTransaction in Own Shares
25th Oct 202112:00 pmRNSHalf yearly unaudited financial report
13th Sep 202112:12 pmRNSPublication of a Prospectus
2nd Sep 202110:30 amRNSIssue of Equity
6th Aug 20212:57 pmRNSChange of Registered Office
30th Jul 20211:18 pmRNSIssue of Equity
8th Jul 20215:07 pmRNSResult of Annual General Meeting
30th Jun 20213:38 pmRNSIssue of Equity and Total voting rights
17th Jun 202110:58 amRNSUnaudited Net Asset Value as at 31 May 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.